Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
5S ribosomal RNA pseudogene 163 (RNA5SP163) is a **processed pseudogene** of the 5S ribosomal RNA gene family, meaning that it is a non-functional, non-protein-coding genomic sequence with high similarity to functional 5S rRNA genes but lacking the ability to be transcribed into functional RNA or produce protein[5][4]. The presence of such pseudogenes is a feature of eukaryotic genomes, which contain many 5S rRNA gene copies and corresponding pseudogenes[1][3]. **Processed pseudogenes** arise from reverse transcription and genomic integration of RNA transcripts but usually lack promoters and are typically transcriptionally inactive[2][4]. There is no evidence that RNA5SP163 has any therapeutic relevance, involvement in disease mechanisms, or use as a biomarker, drug target, or diagnostic entity.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 5S ribosomal RNA pseudogene 163 (RNA5SP163).